Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells
about
New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncologyTargeting sirtuin 1 to improve metabolism: all you need is NAD(+)?NAD+ as a signaling molecule modulating metabolismThe evolutionary portrait of metazoan NAD salvageStructural basis for resistance to diverse classes of NAMPT inhibitorsNAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples.Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: from metabolism to proteomics.Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.Oxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discoveryThe secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasmaPathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation.Novel avenues of drug discovery and biomarkers for diabetes mellitus.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Antimalarial NADPH-Consuming Redox-Cyclers As Superior Glucose-6-Phosphate Dehydrogenase Deficiency Copycats.NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the NucleusPotential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.Dosing profile profoundly influences nicotinic acid's ability to improve metabolic control in ratsThe tuberculosis necrotizing toxin kills macrophages by hydrolyzing NADInhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner.Generation, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human CellsTriple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.The Wnt signaling pathway: aging gracefully as a protectionist?Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors.Erythropoietin: elucidating new cellular targets that broaden therapeutic strategiesThe dynamic regulation of NAD metabolism in mitochondria.Erythropoietin and oxidative stress.The importance of NAD in multiple sclerosisThe vitamin nicotinamide: translating nutrition into clinical care.Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice.Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.Diversification of NAD biological role: the importance of location.Pyridine Dinucleotides from Molecules to Man.Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells.Integrated Metabolomics and Proteomics Highlight Altered Nicotinamide- and Polyamine Pathways in Lung Adenocarcinoma.APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction.Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells.Crystal structure of human nicotinic acid phosphoribosyltransferase.
P2860
Q26745678-422DF138-E1F5-47C6-A0B9-92F54AF4DE8DQ26864685-22418257-E87E-4BDE-B2EE-C82412747995Q26995735-10E0BCB8-4B3A-4063-8C4C-E9A011A1A176Q27318392-4F211C73-DA54-409F-8440-669227A2A290Q28543568-28351AC3-58A7-47F9-AE6B-95580A0073ACQ30366556-4A7D58EF-EB95-4F3E-A13F-4893580E2ED3Q31033957-255619C2-6ABA-4B18-BB42-C41C3995B647Q33583816-AFD7DBC3-577C-49ED-906C-830C9B360E7AQ33682262-7B983476-F6B0-46D0-A9B7-7FCE8D847BD2Q33717008-6F5D59A7-91F9-4C95-9F96-64E80D73FEB5Q33749358-31BB1406-5AB9-462B-A6EF-3A9C23BFA95DQ33779682-3BEB6E31-6217-4C22-BEF1-019C77091FD0Q33985992-45F502DE-2A23-4171-AAFC-171948C71C5AQ34179395-FA5E9AD9-9722-463F-BEE1-0D4B50E9D616Q34552287-C129B40E-BC0E-4B2D-BE15-86BC0924360EQ35157985-93AFEE78-C4E0-4D35-AAF9-252631DA6164Q35541425-CCA09F70-4B56-4246-AD62-760FDA530B7BQ35805959-C0823F1B-175B-4592-95D8-6712A2E5D001Q35876759-F613324E-CCEE-4F06-8B3E-76D1A29F7A42Q35994352-D26537EE-8C64-4E72-86CB-C95574FCE23AQ36029599-D83DB70C-DB4C-4AE6-9D8B-131194D73C68Q36052583-BC0C3F0A-D249-4088-A5C2-4D707FF5DD82Q36283912-64B8BD2E-9705-412C-80B3-1EA9AEE21E18Q36727444-86293621-1959-47F0-B29F-24B7E9CBC9EBQ36728844-72AC710B-92AE-42AE-AD8D-56C98AABA7A6Q36739012-57113360-626A-4653-A118-D0CFCA04F102Q36740470-0C6B2819-6E01-4B3C-913E-8B4BBC0B89D5Q36933021-AB78D330-C49A-4E9D-B2C1-22C119B8D78CQ36944477-63DED93C-0A12-4C2C-A8B2-DD2E03916C66Q37118012-1134722C-263D-4F3E-8655-D48403126C47Q37374047-244F4448-98AB-4E52-AE14-41826FB78B5BQ37621369-E8AE8070-4941-40EC-8E25-DB8BB19D43A2Q37635732-4AA3AC85-A320-4673-806C-2F1104F94AF9Q38121170-FE22F2D1-30C2-4C4E-B99B-57A07F2C6C18Q38668667-A8126E71-A6CE-4D7C-A10F-5F8E538BCB6DQ38956419-680B5ACB-1BFB-44BE-BDFE-38CC343B3E84Q39042259-CB86168D-64DF-4B19-930E-2CDFE8E70EBEQ39207538-9A1330C7-51C2-48B8-B707-A3081C6EC53DQ39247299-87385075-81A2-4604-985D-CEF9B5344DDCQ40870579-BC9C0AF5-B15A-49DF-89AC-5B4776439085
P2860
Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Elevation of cellular NAD leve ...... osyltransferase in human cells
@ast
Elevation of cellular NAD leve ...... osyltransferase in human cells
@en
Elevation of cellular NAD leve ...... osyltransferase in human cells
@en-gb
Elevation of cellular NAD leve ...... osyltransferase in human cells
@nl
type
label
Elevation of cellular NAD leve ...... osyltransferase in human cells
@ast
Elevation of cellular NAD leve ...... osyltransferase in human cells
@en
Elevation of cellular NAD leve ...... osyltransferase in human cells
@en-gb
Elevation of cellular NAD leve ...... osyltransferase in human cells
@nl
prefLabel
Elevation of cellular NAD leve ...... osyltransferase in human cells
@ast
Elevation of cellular NAD leve ...... osyltransferase in human cells
@en
Elevation of cellular NAD leve ...... osyltransferase in human cells
@en-gb
Elevation of cellular NAD leve ...... osyltransferase in human cells
@nl
P2093
P2860
P356
P1476
Elevation of cellular NAD leve ...... osyltransferase in human cells
@en
P2093
Harumi Osago
Kazuo Yamada
Mikako Tsuchiya
Nobumasa Hara
Tatsuya Hashimoto
Tomoko Shibata
P2860
P304
P356
10.1074/JBC.M610357200
P407
P577
2007-08-24T00:00:00Z